Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05036304
Other study ID # H21-00406
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 19, 2022
Est. completion date November 27, 2023

Study information

Verified date January 2024
Source University of British Columbia
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Aerobic exercise is an evidence-based approach to mitigate cognitive decline in older adults with mild cognitive impairment (MCI). Emerging evidence suggests that the cognitive benefits of exercise may be enhanced when performed in outdoor, natural settings, as compared to indoor or built settings. Thus, the investigators aim to compare the effects of outdoor versus indoor walking programs on cognitive function among older adults with MCI. Secondary outcomes are motor function, emotional well-being, health-related behaviours, and quality of life. Participants will be randomly assigned to a 12--week, 3x/week program of either outdoor walking on forest trails or indoor walking on a treadmill. A 3-month followup will also be completed after trial completion.


Description:

Study Design: A 12-week, single-blinded, trial with two experimental arms. Participants will be randomized (1:1) to either outdoor walking (OP) or indoor walking or cycling (IP). Measurement will occur in person at baseline and at trial completion. Additionally, follow-up measurement of questionnaire-based outcomes will occur via email or phone at 3 months following trial completion. Outcome assessors will be trained by the research team and blinded to group allocation of the participants. Participants: 68 community-dwelling adults aged 65-80 years old with probable MCI and in sufficient health to participate in aerobic exercise of moderate intensity Interventional Arms: All participants will receive three group-based training sessions per week for 12 weeks, under the supervision of instructors with a relevant background and first aid certification. Each session will consist of 10 min of warm-up, 40 min of aerobic exercise, and 10 min of cool-down. For both OP and IP, aerobic exercise will be progressive and of moderate intensity. During training, each participant will wear a heart rate monitor and will be asked to work initially at approximately 45% of their heart rate reserve (HRR) and gradually progress to reach the target of 70% of HRR over the 12-week study period. Participants will also subjectively monitor workout intensity using the 20-point Borg's Rating of Perceived Exertion. OP participants will walk or jog a pre-determined route in trails of an urban forest (Pacific Spirit Park). IP participants will walk or jog on treadmills in the Exercise Prescription Suite of the Centre for Hip Health and Mobility (CHHM). Both OP and IP training groups will have a participant to instructor ratio of 3:1. To promote adherence to the exercise program, sessions will be offered at times that are convenient for each individual participant. Protocols will be adjusted as necessary to align with COVID-19 guidelines. Measurement of descriptors and outcomes: Standardized protocols will be developed and study personnel will be trained. Assessors will be blinded to treatment allocation. We will measure descriptors and outcomes at baseline and at trial completion. Each measurement session will be 2 hours in duration. For these measurements, participants will complete a session of behavioural and clinical testing at the VCH Research Pavilion and the CHHM. To account for time-of-day effects, each participant's session start time will be the same at both timepoints, and the order of the assessments will be the same for all participants.


Recruitment information / eligibility

Status Completed
Enrollment 72
Est. completion date November 27, 2023
Est. primary completion date July 10, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 65 Years to 80 Years
Eligibility Inclusion Criteria: 1. achieve a score =18/30 and =24/30 on the Montreal Cognitive Assessment 2. have subjective cognitive impairment based on interview 3. have no significant impairment in daily function, as determined by a score =6/8 on the Lawton and Brody Instrumental Activities of Daily Living Scale 4. no diagnosis of dementia 5. aged 65 to 80 years old 6. live independently in their own home 7. live in the Greater Vancouver area 8. read, write, and speak English with acceptable visual and auditory acuity 9. are cleared to start a supervised exercise programme based on the Physical Activity Readiness Questionnaire for Everyone 10. able to walk independently 11. able to provide informed consent Exclusion Criteria: 1. participating in regular moderate to vigorous intensity aerobic exercise in the last 3 months 2. planning to enroll in a concurrent exercise or drug trial targeting cognitive function 3. diagnosed with a neurological, cerebrovascular, or psychiatric disease, or other chronic medical condition requiring intensive treatment and monitoring 4. have major impairments in eyesight, hearing or motor movements 5. have clinically significant neuropathy or musculoskeletal or joint disease 6. have a recent traumatic brain injury, including concussions 7. are currently using prescribed cognitive intervention or electromagnetic stimulation 8. at the time of recruit, indicate they recently (within the last 2 months) or will start taking drugs that significantly alter cognition, movement, or affect, such as cholinesterase inhibitors, anticholinergics, hormone replacement therapy, or antidepressants

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Aerobic Exercise Indoors
Each session will consist of 10 min of warm-up, 40 min of aerobic exercise, and 10 min of cool-down. Aerobic exercise will be progressive and of moderate intensity. During training, each participant will wear a heart rate monitor and will be asked to work initially at approximately 45% of his/her target heart rate (i.e., heart rate reserve (HRR)) and gradually progress to reach the target of 70% of HRR over the 12-week study period. Participants will also subjectively monitor workout intensity using the 20-point Borg's Rating of Perceived Exertion. Participants will walk or jog on treadmills or cycle on stationary bikes in the Exercise Prescription Suite of the Centre for Hip Health and Mobility.
Aerobic Exercise Outdoors
Each session will consist of 10 min of warm-up, 40 min of aerobic exercise, and 10 min of cool-down. Aerobic exercise will be progressive and of moderate intensity. During training, each participant will wear a heart rate monitor and will be asked to work initially at approximately 45% of his/her target heart rate (i.e., heart rate reserve (HRR)) and gradually progress to reach the target of 70% of HRR over the 12-week study period. Participants will also subjectively monitor workout intensity using the 20-point Borg's Rating of Perceived Exertion. Participants will walk or jog pre-determined routes in trails of an urban forest (Pacific Spirit Park)

Locations

Country Name City State
Canada University of British Columbia Vancouver British Columbia

Sponsors (1)

Lead Sponsor Collaborator
University of British Columbia

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in List Sorting Performance This is a measure of working memory Baseline to 12 weeks
Primary Change in Digits Span Forwards and Backwards This is a measure of working memory. Baseline to 12 weeks
Secondary Change in NIH Toolbox Cognitive Battery Performance Measures different cognitive domains, with a focus on executive functions Baseline to 12 weeks
Secondary Change in Digit Symbol Substitute Test A measure of processing speed and executive functions. Baseline to 12 weeks
Secondary Change in the Short Physical Performance Battery A measure of balance and mobility Baseline to 12 weeks
Secondary Change in Timed Up and Go Test A measure of general mobility Baseline to 12 weeks
Secondary Change in State-Trait Anxiety Inventory A measure of anxiety Baseline to 12 weeks and 6 months
Secondary Change in Centre for Epidemiological Studies Depression Scale A measure of depressive symptoms Baseline to 12 weeks and 6 months
Secondary Change in Blood Pressure Systolic and diastolic blood pressure Baseline to 12 weeks
Secondary Change in sensor measured sleep Using MotionWatch 8 to measure sleep quality Baseline to 12 weeks
Secondary Change in sensor measured physical activity Using MotionWatch 8 to measure levels and amount of physical activity Baseline to 12 weeks
Secondary Change in Physical Activity Scale for the Elderly A self-report measure of physical activity, higher scores indicate higher activity Baseline to 12 weeks and 6 months
Secondary Change in Pittsburgh Sleep Quality Index A self-report measure of sleep quality, higher scores indicate poorer sleep quality Baseline to 12 weeks and 6 months
Secondary Change in ICEpop CAPability measure for Older people (ICECAP-O) A measure of quality of life, higher values indicate better quality of life Baseline to 12 weeks and 6 months
Secondary 5-level EuroQoL 5-dimension (EQ-5D-5L) questionnaire A measure of quality of life, higher values indicate better quality of life Baseline to 12 weeks and 6 months
Secondary Change in gait speed, derived from Short Physical Performance Battery A measure of walking speed. Baseline to 12 weeks.
Secondary Changes in hemodynamics of the brain as measured by fNIRS during the N-Back Task A measure of brain function. Baseline to 12 weeks.
Secondary Changes in Feeling Scale Measure of affective valence Baseline to 12 weeks.
Secondary Changes in Exercise Enjoyment Scale An affective measure Baseline to 12 weeks.
Secondary Changes in Felt Arousal Scale Measure of affective activation Baseline to 12 weeks
See also
  Status Clinical Trial Phase
Completed NCT05433233 - Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension N/A
Recruiting NCT06032065 - Sequential Multiple Assessment Randomized Trial of Exercise for PAD: SMART Exercise for PAD (SMART PAD) Phase 3
Completed NCT05293730 - Trial of the Impact of the Electronic Frailty Integrated With Social Needs N/A
Recruiting NCT03932162 - Gene Expression Changes In Young and Geriatric Skin Early Phase 1
Completed NCT04064528 - Effects of Age on Amino Acid Delivery to Tendon N/A
Completed NCT03366129 - Blood-Brain Barrier Disruption in People With White Matter Hyperintensities Who Have Had a Stroke
Completed NCT06029920 - Influence of Overground Walking on Biomarkers, Cognitive Function, and Quality of Life in Elderly With Mild Cognitive Impairment N/A
Recruiting NCT05543980 - Leg Heat Therapy in Elderly Individuals Phase 2
Recruiting NCT05566938 - Study to Design a Precision Nutrition Strategy at a Group Level in the Elderly N/A
Completed NCT04894929 - Comprehensive Geriatric Assessment in the Monitoring of Functional Improvement N/A
Not yet recruiting NCT06071130 - Emotion, Aging, and Decision Making N/A
Enrolling by invitation NCT04641663 - Multi-target Dietary Supplement Tolerability in an Aging Population (MTDSST) N/A
Completed NCT04088006 - The Evaluation of Efficacy and Safety of Hyaluronic Acid Injection on Skin Moisturization and Elasticity N/A
Completed NCT03695081 - Patient Pathway Pharmacist - Optimal Drug-related Care N/A
Recruiting NCT05424263 - Acetate and Age-associated Arterial Dysfunction Phase 2
Completed NCT05601713 - Mitigating Heat-induced Physiological Strain and Discomfort in Older Adults Via Lower Limb Immersion and Neck Cooling N/A
Completed NCT04551339 - Zinc Versus Multivitamin Micronutrient Supplementation in the Setting of COVID-19 N/A
Recruiting NCT04997577 - Speech Perception and High Cognitive Demand N/A
Completed NCT05922475 - Efficacy of Pre-sleep or Post-exercise Protein During 12 Weeks of Resistance Exercise Training N/A
Completed NCT04015479 - Peanut Protein Supplementation to Augment Muscle Growth and Improve Markers of Muscle Quality and Health in Older Adults N/A